AI techniques massively accelerate the search for Parkinson’s disease treatments

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Iowa Doc Sues Hospital Over COVID-19

Amy­lyx an­nounced Thurs­day morn­ing that it will pull its ALS drug Re­lyvrio from the US and Cana­di­an mar­kets. The de­ci­sion comes as Amy­lyx will al­so

No­var­tis and BeiGene have mu­tu­al­ly agreed to axe their col­lab­o­ra­tion on a Phase III TIG­IT in­hibitor, mark­ing an­oth­er de­rail­ment in a field once thought to